08Jul/13

Breast cancer drug everolimus fails to get NICE approval – OnMedica


The Guardian

Breast cancer drug everolimus fails to get NICE approval
OnMedica
The breast cancer drug everolimus (also called Afinitor) is not cost effective for the NHS. This is the recommendation from the National Institute for Health and Care Excellence (NICE) which today refused to give the green-light to everolimus
Novartis breast cancer drug Afinitor not cost effective for NHS, says draft The Pharma Letter
Breast cancer drug rulingITV News
Novartis Cancer Drug Fails to Win U.K. Cost Agency’s NodBloomberg
The Guardian –Guernsey Press and Star (subscription)
all 27 news articles »
08Jul/13

A survey of TREM2 antibodies reveals neuronal but not microglial staining in … – 7thSpace Interactive (press release)

A survey of TREM2 antibodies reveals neuronal but not microglial staining in
7thSpace Interactive (press release)
Recently, two independent studies indicated a strong association between a rare rs75932628-T variant encoding non-functional R47H in the TREM2 gene and an increased risk for Alzheimer’s disease (AD). TREM2 expressed on monocytes/macrophages, 

08Jul/13

'Our boy's death has saved two lives' – Coventry family's story highlights … – Coventry Telegraph


Coventry Telegraph

‘Our boy’s death has saved two lives’ – Coventry family’s story highlights
Coventry Telegraph
Today is the start of National Transplant Week and the family’s story is being highlighted by Coventry University Hospital to raise awareness of the Organ Donor Register. Aeron is the face of the hospital’s appeal. Mandi said: “We’ll miss him every